GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Senseonics Holdings Inc (AMEX:SENS) » Definitions » EBIT

Senseonics Holdings (Senseonics Holdings) EBIT : $-49.28 Mil (TTM As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Senseonics Holdings EBIT?

Senseonics Holdings's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2023 was $-15.47 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was $-49.28 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Senseonics Holdings's annualized ROC % for the quarter that ended in Dec. 2023 was -411.35%. Senseonics Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -2,221.22%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Senseonics Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -25.78%.


Senseonics Holdings EBIT Historical Data

The historical data trend for Senseonics Holdings's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Senseonics Holdings EBIT Chart

Senseonics Holdings Annual Data
Trend Jun14 Jun15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -103.75 -159.00 -285.75 160.82 -49.28

Senseonics Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.46 5.98 -18.11 -21.68 -15.47

Competitive Comparison of Senseonics Holdings's EBIT

For the Medical Devices subindustry, Senseonics Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Senseonics Holdings's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Senseonics Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Senseonics Holdings's EV-to-EBIT falls into.



Senseonics Holdings EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-49.28 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Senseonics Holdings  (AMEX:SENS) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Senseonics Holdings's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

ROC % (Q: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2023 ) + Invested Capital (Q: Dec. 2023 ))/ count )
=-68.016 * ( 1 - 0% )/( (15.855 + 17.215)/ 2 )
=-68.016/16.535
=-411.35 %

where

Note: The Operating Income data used here is four times the quarterly (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Senseonics Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2023  Q: Dec. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-61.872/( ( (0.934 + max(1.833, 0)) + (1.184 + max(1.62, 0)) )/ 2 )
=-61.872/( ( 2.767 + 2.804 )/ 2 )
=-61.872/2.7855
=-2,221.22 %

where Working Capital is:

Working Capital(Q: Sep. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(3.45 + 9.726 + 5.546) - (12.803 + 0 + 4.086)
=1.833

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(4.532 + 8.776 + 5.201) - (11.549 + 0 + 5.34)
=1.62

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Senseonics Holdings's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2023 )
=-49.283/191.202
=-25.78 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Senseonics Holdings EBIT Related Terms

Thank you for viewing the detailed overview of Senseonics Holdings's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Senseonics Holdings (Senseonics Holdings) Business Description

Traded in Other Exchanges
Address
20451 Seneca Meadows Parkway, Germantown, MD, USA, 20876-7005
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of the glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.
Executives
Sharon Larkin director C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Douglas A Roeder director 160 BOVET RD, SUITE 408, C/O DELPHI VENTURES, SAN MATEO CA 94402
Frederick T. Sullivan officer: Chief Financial Officer C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Mukul Jain officer: VP Operations, Qual & Reg 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Edward Fiorentino director 1350 KENNICOTT DRIVE, LAKE FOREST IL 60045
Mirasol Panlilio officer: VP Global Sales & Marketing 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Timothy T Goodnow director, officer: President & Chief Exec Officer 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Francine Kaufman officer: Chief Medical Officer C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Kenneth L Horton officer: GC & Corp. Development Advisor VERTEX PHARMACEUTICALS INCORPORATED, 130 WAVERLY STREET, CAMBRIDGE MA 02139
Nick B. Tressler officer: Chief Financial Officer C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 208786
Anthony R. Raab director C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
John Marotta director C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Stephen P Defalco director ONE EXETER STREET, BOSTON MA 02116
Douglas S Prince director 20 TILESTON STREET, PH4, BOSTON MA 02113
Edelman Steven director C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876

Senseonics Holdings (Senseonics Holdings) Headlines

From GuruFocus